FMRP expression as a potential prognostic indicator in fragile X syndrome

American Journal of Medical Genetics

Volumn 84, Issue 3, 1999, Pages 250-261

  Tassone, Flora ^a,b   Hagerman, Randi J ^b,c   Iklé, David N ^d   Dyer, Pamela N ^a   Lampe, Megan ^b   Willemsen, Rob ^e   Oostra, Ben A ^e   Taylor, Annette K ^a  

^a Kimball Genetics Inc   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Activation ratio; Clinical correlation; FMR1 mutation; FMRP; Fragile X syndrome; Immunocytochemistry; Mosaic; Partial methylation

Indexed keywords

MUTANT PROTEIN;

ADULT; ARTICLE; CORRELATION FUNCTION; DNA DETERMINATION; DNA METHYLATION; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; IMMUNOCYTOCHEMISTRY; INFANT; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MOSAICISM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LINEAR MODELS; MALE; MIDDLE AGED; MOSAICISM; NERVE TISSUE PROTEINS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA-BINDING PROTEINS;

EID: 0033612144     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4     Document Type: Article

References (64)

1. Abrams MT, Reiss AL, Freund LS, Baumgardner TL, Chase GA, Denckla MB. 1994. Molecular-neurobehavioral associations in females with the fragile X full mutation. Am J Med Genet 51:317-327.
2. Ashley CT Jr, Wilkinson KD, Reines D, Warren ST. 1993. FMR-1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-565.
3. Barkley RA. 1990. Attention deficit hyperactivity disorder A handbook for diagnosis and treatment. New York: The Guilford Press.
4. th International Workshop on Fragile X and X-linked mental retardation. Tromso Norway. August 2-5.
5. Brown WT, Houck GE, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC. 1993. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575.
6. Cohen IL, Nolin SL, Sudhalter V, Ding X-H, Dobkin CS, Brown TW. 1996. Mosaicism for the FMR1 gene influences adaptative skills development in fragile X -affected males. Am J Med Genet 64:365-389.
7. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT. 1997. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401-5404.
8. de Graaff E, de Vries BBA, Willemsen R, van Hemel JO, Mohkamsing S, Oostra BA, van den Ouweland AMV. 1996. The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells. Am J Med Genet 64:302-308.
9. de Graaff E, Willemsen R, Zhong N, de Die-Smulders CEM, Brown TW, Freling G, Oostra BA. 1995. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X subject with a lung tumor. Am J Hum Genet 57:609-618.
10. de Vries BBA, Jansen CCAM, Duits AA, Verheij C, Willemsen R, van Hemel JO, van den Ouweland AMW, Niermeijer MF, Oostra BA, Halley DJJ. 1996a. Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family. J Med Genet 33:1007-1010.
11. de Vries BBA, Wiegers AM, de Graaff E, Verkerk AJMH, Van Hemel JO, Halley DJJ, Fryns J-P, Curf LM, Niermeijer MF, Oostra BA. 1993. Mental status and fragile X expression in relation to FMR1 gene mutation. Eur J Hum Genet 1:72-79.
12. de Vries BBA, Wiegers AM, Smits APT, Mohkamsing S, Duivenvoorden HJ, Fryns JP, Curfs LMG, Halley DJJ, Oostra BA, van der Ouweland AMW, Niermeijer MF. 1996b. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 58:1025-1032.
13. Devys D, Biancalana V, Rousseau F, Boué J, Mandel J-L, Oberlé I. 1992. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet 43:208-216.
14. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
15. Dobkin CS, Nolin SL, Cohen I, Sudhalter V, Bialer MG, Ding X-H, Jenkins EC, Zhong N, Brown WT. 1996. Tissue differences in fragile X mosaics: mosaicism in blood cells may differ greatly from skin. Am J Med Genet 64:296-301.
16. Eberhart DE, Malter HE, Feng Y, Warren ST. 1996. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5:1083-1091.
17. Feng Y, Lakkis D, Devy D, Warren ST. 1995a. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet 56:106-113.
18. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST. 1995b. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734.
19. Hagerman RJ. 1996. Physical and behavioral phenotype. In: Hagerman RJ, Cronister AC, editors. Fragile X syndrome: diagnosis, treatment, and research. 2nd edition. Baltimore, MD: Johns Hopkins University Press. p 3-87.
20. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O'Connor RA, Seydel C, Mazzocco MMM, Snow K, Thibodeau SN, Kuhl D, Nelson DL, Caskey CT, Taylor AK. 1994. High functioning fragile X males: demonstration of an unmethylated, fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51:298-308.
21. Hull C, Hagerman RJ. 1993. A study of the physical, behavioral, and medical phenotype, including anthropometric measures of females with Fragile X syndrome. AJDC 147:1236-1241.
22. Khandijan EW, Corbin F, Woerly S, Rousseau F. 1996. The fragile X mental retardation protein is associated with ribosomes. Nat Genet 12:91-93.
23. Lachiewicz AM, Spiridigliozzi GA, McConkie-Rosell A, Burgess D, Feng Y, Warren ST, Tarleton JA. 1996. A fragile X male with a broad smear on Southern blot analysis representing 100-500 CGG repeats and no methylation at the Eagl site of the FMR-1 gene. Am J Med Genet 64:278-282.
24. Loesch DZ, Huggins R, Hay DA, Gedeon AK, Mulley JC, Sutherland GR. 1993a. Genotype-phenotype relationships in fragile X syndrome: a family study. Am J Hum Genet 53:1064-1073.
25. Loesch DZ, Huggins RM, Chin WF. 1993b. Effect of fragile X on physical and intellectual traits estimated by pedigree analysis. Am J Med Genet 46:415-422.
26. Maddalena A, Yadvish KN, Spence CW, Howard-Peebles PN. 1996. A fragile X mosaic male with a cryptic full mutation detected in epithelium but not in blood. Am J Med Genet 64:309-312.
27. McConkie-Rosell A, Lachewicz AM, Spiridigliozzi GA, Tarleton J, Scheonwald S, Phelan CM, Goonewardena P, Ding X, Brown WT. 1993. Evidence that methylation of the FMR-1 locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet 53:800-809.
28. Merenstein SA, Shyu V, Sobesky EW, Staley L, Berry-Kravis E, Nelson LD, Lugenbeel KA, Taylor AK, Pennington BF, Hagerman RJ. 1994. Fragile X syndrome in a normal IQ male with learning and emotional problems. J Am Acad Child Adolesc Psychiatry 33:1316-1321.
29. Merenstein SA, Sobesky WE. Taylor AK, Riddle JE, Tran HX, Hagerman RJ. 1996. Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J Med Genet 64:388-394.
30. Nolin SL, Glicksman A, Houck GE Jr, Brown TW, Dobkin CS. 1994. Mosaicism in fragile X affected males. Am J Med Genet 51:509-512.
31. Oberlé, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boué J, Bertheas MF, Mandel J-L. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
32. Oostra BA. 1996. FMR1 protein studies and animal model for fragile X syndrome. In: Hagerman RJ, Cronister AC, editors. Fragile X syndrome: diagnosis, treatment, and research. 2nd edition. Baltimore, MD: Johns Hopkins University Press. p 193-209.
33. Rattazzi MC, Ioannou YA. 1996. Molecular approaches to therapy. In: Hagerman RJ, Cronister AC, editors. Fragile X syndrome: diagnosis, treatment, and research. 2nd edition. Baltimore, MD: Johns Hopkins University Press. p 412-452.
34. Reiss AL, Freund LS, Baumgardner TL, Abrams MT, Denckla. 1995. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet 11:331-334.
35. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacobs PA, Schwartz C, Mandel J-L. 1994a. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet 55:225-237.
36. Rousseau F, Robb LJ, Rouillard P, der Kaloustian VM. 1994b. No mental retardation in a man with 40% abnormal methylation at the FMR-1 locus and transmission of sperm cell mutations as premutations. Hum Mol Genet 3:927-930.
37. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G. 1994. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77:33-39.
38. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74:291-298.
39. Siomi MC, Zhang Y, Siomi H, Dreyfuss G. 1996. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 16:3825-3832.
40. Smeets HJM, Smits APT, Verheij CE, Theelen JPG, Willemsen R, van de Burgt I, Hoogeveen AT, Oosterwijk JC, Oostra BA. 1995. Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 4:2103-2108.
41. Sobesky WE, Taylor AK, Pennington BF, Bennetto L, Porter D, Riddle J, Hagerman RJ. 1996. Molecular/clinical correlations in females with fragile X. Am J Med Genet 64:340-345.
42. Staley LW, Hull CE, Mazzocco MM, Thibodeau SN, Snow K, Wilson VL, Taylor AK, McGavran L, Weiner D, Riddle J, O'Connor R, Hagerman RJ. 1993. Molecular-clinical correlations in fragile X children and adults. AJDC 147:723-726.
43. Steyaert J, Borghgraef M, Legius E, Fryns J-P. 1996. Molecular intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene. Am J Med Genet 64:274-277.
44. Sutherland GR, Gedeon A, Kornman L, Donnelly A, Byard RW, Mulley JC, Kremer E, Lynch M, Pritchard M, Yu S, Richard RI. 1991. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med 325:1720-1722.
45. Tamanini F, Meijer N, Verheij C, Willems PJ, Galjaard H, Oostra BA, Hoogeveen AT. 1996. FMRP is associated to the ribosomes via RNA. Hum Mol Genet 5:809-813.
46. Tan SS, Faulkner-Jones B, Breen SJ, Walsh M, Bertram JF, Reese BE. 1995. Cell dispersion patterns in different cortical regions studied with an X-inactivation transgenic marker. Development 121:1029-1039.
47. Tassone F, Hagerman RJ, Gane LW, Taylor AK (1999): Strong similarities of the FMR1 mutation in multiple tissues: postmortem studies of a male with a full mutation and a male carrier of a premutation. Am J Med Genet 84:240-244.
48. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, Staley LW, Hagerman RJ. 1994a. Molecular predictors of cognitive involvement in females carriers of fragile X syndrome. JAMA 271:507-514.
49. Taylor AK, Safanda JF, Lugenbeel KA, Nelson DL, Hagerman RJ. 1994b. Molecular and phenotypic studies of fragile X males with variant methylation of the FMR1 gene reveal that the degree of methylation influences clinical severity. Am J Hum Genet 55:(Suppl):A18.
50. Taylor AK, Tassone F, Dyer PN, Hersch SM, Harris JB, Greenough WT, Hagerman RJ. 1999. Tissue heterogeneity of the FMR1 mutation in a high functioning male with fragile X syndrome. Am J Med Genet 84: 233-239.
51. Verheij C, Bakker CE, deGraaff E, Keulemans J, Willemsen R, Verkerk AJMH, Galjaard H, Reuser AJJ, Hoogeveen AT, Oostra BA. 1993. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724.
52. Verheij C, deGraaff E, Bakker CE, Willemsen R, Willems PJ, Meijer N, Galjaard H, Reuser AJJ, Oostra BA, Hoogeveen AT. 1995. Characterization of FMR1 proteins isolated from different tissues. Hum Mol Genet 4:895-901.
53. Wang Z, Taylor AK, Bridge JA. 1996. FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J Med Genet 33:376-378.
54. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT. 1997. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-5400.
55. Willemsen R, Bontekoe C, Tamanini F, Galjaard H, Hoogeveen A, Oostra BA. 1996a. Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem Biophys Res Commun 225:27-33.
56. Willemsen R, Los FJ, Mohkamsing S, van den Ouweland A, Deelen W, Galjaard H, Oostra BA. 1997a. Rapid antibody test for prenatal diagnosis of Fragile X syndrome on amniotic fluid cells: a new appraisal. J Med Genet 34:250-251.
57. Willemsen R, Mohkamsing S, de Vries BBA, Devys D, van den Ouweland A, Mandel J-L, Galjaard. H, Oostra BA. 1995. Rapid antibody test for fragile X syndrome. Lancet 345:1147-1148.
58. Willemsen R, Oosterwijk JO, Los FJ, Galjaard H, Oostra BA. 1996b. Prenatal diagnosis of fragile X syndrome. Lancet 348:967-968.
59. Willemsen R, Smits A, Mohkamsing S, van Beerendonk H, de Haan A, de Vries B, van den Ouweland A, Sistermans E, Galjaard H, Oostra BA. 1997b. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 99:308-311.
60. Wöhrle D, Hennig I, Vogel W, Steinbach P. 1993. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet 4:140-142.
61. Wöhrle D, Hirst MC, Kennerknech I, Davies KE, Steinbach P. 1992. Genotype mosaicism in fragile X fetal tissues. Hum Genet 89:114-116.
62. Wöhrle D, Salat U, Glaser D, Mücke J, Meisel-Stosiek M, Schindler D, Vogel W, Steinbach P. 1998. Unusual mutation in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet 35:103-111.
63. Wright-Talamante C, Cheema A, Riddle JE, Luckey DW, Taylor AK, Hagerman RJ. 1996. A controlled study of longitudinal IQ changes in females and males with Fragile X syndrome. Am J Med Genet 64: 350-355.
64. Yanghong G, Lugenbeel KA, Vockley JG, Grody WW, Nelson DL. 1994. A de novo deletion in FMR1 in a subject with developmental delay. Hum Mol Genet 3:1705-1706.